how to choose among the phosphate binders for patients with chronic kidney disease
May 2011
There's confusion about how to choose among the phosphate binders for patients with chronic kidney disease.
These have similar efficacy for lowering phosphate levels...but they vary in adverse effects, cost, and number of pills needed.
Aluminum hydroxide isn't used chronically anymore. Aluminum accumulates and leads to bone disease, dementia, and death.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive